Connection

DAVID POPLACK to Kinetics

This is a "connection" page, showing publications DAVID POPLACK has written about Kinetics.
Connection Strength

0.286
  1. Dose-dependent pharmacokinetics of all-trans-retinoic acid. J Natl Cancer Inst. 1992 Sep 02; 84(17):1332-5.
    View in: PubMed
    Score: 0.022
  2. The effect of methotrexate on the bioavailability of oral 6-mercaptopurine. Clin Pharmacol Ther. 1987 Apr; 41(4):384-7.
    View in: PubMed
    Score: 0.015
  3. Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. J Clin Oncol. 1987 Feb; 5(2):202-7.
    View in: PubMed
    Score: 0.015
  4. Pharmacokinetics of intraventricular and intravenous N,N',N''-triethylenethiophosphoramide (thiotepa) in rhesus monkeys and humans. Cancer Res. 1986 Dec; 46(12 Pt 1):6101-4.
    View in: PubMed
    Score: 0.015
  5. The pharmacology of orally administered chemotherapy. A reappraisal. Cancer. 1986 Jul 15; 58(2 Suppl):473-80.
    View in: PubMed
    Score: 0.014
  6. Cellular pharmacokinetics of mercaptopurine in human neoplastic cells and cell lines. Cancer Res. 1985 Sep; 45(9):4156-61.
    View in: PubMed
    Score: 0.014
  7. Pharmacokinetics of tiazofurin in the plasma and cerebrospinal fluid of rhesus monkeys. Cancer Res. 1985 May; 45(5):2037-9.
    View in: PubMed
    Score: 0.013
  8. Kinetic model for disposition of 6-mercaptopurine in monkey plasma and cerebrospinal fluid. Am J Physiol. 1985 Feb; 248(2 Pt 2):R147-56.
    View in: PubMed
    Score: 0.013
  9. Prevention of methotrexate cytotoxicity by asparaginase inhibition of methotrexate polyglutamate formation. Cancer Res. 1985 Jan; 45(1):217-20.
    View in: PubMed
    Score: 0.013
  10. Plasma and cerebrospinal fluid pharmacokinetics of recombinant interferon alpha A in monkeys: comparison of intravenous, intramuscular, and intraventricular delivery. Cancer Drug Deliv. 1985; 2(4):247-53.
    View in: PubMed
    Score: 0.013
  11. Effect of intravenous dose and schedule on cerebrospinal fluid pharmacokinetics of 5-fluorouracil in the monkey. Cancer Res. 1984 Nov; 44(11):4929-32.
    View in: PubMed
    Score: 0.013
  12. Cytosine arabinoside cerebrospinal fluid kinetics. Clin Pharmacol Ther. 1984 Jun; 35(6):826-30.
    View in: PubMed
    Score: 0.012
  13. Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone. Cancer Res. 1984 Apr; 44(4):1698-701.
    View in: PubMed
    Score: 0.012
  14. Inhibition of first-pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinol. Clin Pharmacol Ther. 1983 Dec; 34(6):810-7.
    View in: PubMed
    Score: 0.012
  15. Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered? N Engl J Med. 1983 Apr 28; 308(17):1005-9.
    View in: PubMed
    Score: 0.011
  16. Pharmacokinetics of 6-mercaptopurine (6MP) in the monkey. I. Disposition from plasma and cerebrospinal fluid following iv bolus. Drug Metab Dispos. 1983 Jan-Feb; 11(1):5-9.
    View in: PubMed
    Score: 0.011
  17. Clinical pharmacology of 9-beta-D-arabinofuranosyladenine in combination with 2'-deoxycoformycin. Cancer Res. 1982 Sep; 42(9):3884-6.
    View in: PubMed
    Score: 0.011
  18. Cerebrospinal fluid levels of 2'-deoxycoformycin after systemic administration in monkeys. J Natl Cancer Inst. 1982 Mar; 68(3):391-3.
    View in: PubMed
    Score: 0.011
  19. L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans. Cancer Res. 1981 Nov; 41(11 Pt 1):4554-8.
    View in: PubMed
    Score: 0.010
  20. Pharmacokinetic study of cerebrospinal fluid penetration of cis-diamminedichloroplatinum (II). Cancer Chemother Pharmacol. 1981; 5(4):257-60.
    View in: PubMed
    Score: 0.010
  21. Pharmacokinetics of ICRF-187 in the cerebrospinal fluid of subhuman primates. Cancer Treat Rep. 1980 Apr-May; 64(4-5):734-6.
    View in: PubMed
    Score: 0.009
  22. Active clearance of corticotropin-releasing factor from the cerebrospinal fluid. Neuroendocrinology. 1985 Jan; 40(1):84-7.
    View in: PubMed
    Score: 0.003
  23. Plasma and cerebrospinal fluid pharmacokinetics of acivicin in Ommaya reservoir-bearing rhesus monkeys. Cancer Treat Rep. 1982 Jun; 66(6):1333-41.
    View in: PubMed
    Score: 0.003
  24. Misonidazole blood and cerebrospinal fluid kinetics in monkeys following intravenous and intrathecal administration. Eur J Cancer (1965). 1981 Jan; 17(1):29-34.
    View in: PubMed
    Score: 0.002
  25. Active transport of methotrexate from cerebrospinal fluid in humans. Cancer Res. 1980 Jul; 40(7):2184-7.
    View in: PubMed
    Score: 0.002
  26. Pharmacokinetics of vincristine in the cerebrospinal fluid of subhuman primates. Cancer Res. 1980 Mar; 40(3):722-4.
    View in: PubMed
    Score: 0.002
  27. Acceleration of myeloid recovery from cyclophosphamide-induced leukopenia by pretreatment with Bacillus Calmette-Gu?rin. Cancer Res. 1978 Apr; 38(4):1049-51.
    View in: PubMed
    Score: 0.002
  28. Effect of Corynebacterium parvum, methanol-extraction residue of BCG, and levamisole on macrophage random migration, chemotaxis, and pinocytosis. J Natl Cancer Inst. 1977 Jun; 58(6):1753-7.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.